Girindra Raval, MD

Girindra Raval, MD, is an associate professor in the Department of Medicine: Hematology and Oncology at the Medical College of Georgia of Augusta University.

Articles by Girindra Raval, MD

Girindra Raval, MD; Anand Jillella, MD, J. Harold Harrison, MD Distinguished University Chair in Medicine, professor, medicine & pediatrics, chief, Division of Hematology/Oncology, Augusta University Medical College of Georgia

Passion and Innovation Formed the Foundation for a Leading Cancer Program: With Girindra Raval, MD; and Anand Jillella, MD

ByGirindra Raval, MD,Anand Jillella, MD

October 15th 2025

Raval and Jillella discussed Jillella's career journey, starting from his oncology internship in 1989 to establishing a bone marrow transplant program.

Frank’s Path to Advancing Hematology Through Innovation and Discovery: With Girindra Raval, MD; and David A. Frank, MD, PhD, FACP

ByGirindra Raval, MD,David A. Frank, MD, PhD, FACP

August 13th 2025

Girindra Raval, MD, and David A. Frank, MD, PhD, FACP, discuss Frank’s journey, through his undergraduate studies at MIT, and completion of an MD/PhD program at Yale University.

Cancer, Character, and Calling: The Oncologist's Journey

Cortes’ Journey Helps Reshape Hematologic Cancer Care: With Girindra Raval, MD; and Jorge Cortes, MD

ByGirindra Raval, MD,Jorge Cortes, MD

July 23rd 2025

Drs Raval and Cortes discuss Dr. Cortes’ journey through the hematologic oncology field and highlight ongoing work in the hematologic oncology space.

Girindra Raval, MD

Articles by Girindra Raval, MD

Passion and Innovation Formed the Foundation for a Leading Cancer Program: With Girindra Raval, MD; and Anand Jillella, MD

Frank’s Path to Advancing Hematology Through Innovation and Discovery: With Girindra Raval, MD; and David A. Frank, MD, PhD, FACP

Cortes’ Journey Helps Reshape Hematologic Cancer Care: With Girindra Raval, MD; and Jorge Cortes, MD

Latest Updated Articles

Trending on OncLive

Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma

Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer

PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer

Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies

Nuvisertib Yields Strong Safety, Promising Efficacy in R/R Myelofibrosis